The current Central Nervous System Therapeutics Market Size was valued at USD 178.89 billion in 2024, underscoring its immense scale and importance within the global pharmaceutical industry. This substantial valuation is a reflection of the high cost associated with both chronic management of conditions like Multiple Sclerosis and the rapidly emerging high-value specialty drugs for Alzheimer's and other neurodegenerative diseases.

The projection of the Central Nervous System Therapeutics Market Size to USD 360.29 billion by 2035 is a clear indicator of the anticipated success of drug pipelines targeting major CNS disorders. This significant increase is directly linked to the expected launch of several disease-modifying therapies, regulatory approvals expanding drug use to pediatric populations (e.g., in Multiple Sclerosis), and the continued global recognition of mental health as a critical, high-spending therapeutic area.Central Nervous System Therapeutics Market